High0/2 relationships sourcedProfile verified Aug 29, 2026

30-Second Executive Brief

Executive Assessment

Philips functions as an established institution within Healthcare & Life Sciences, backed by 0% sourcing coverage, with accelerating strategic relevance.

  • Maintains 2 mapped relationships across the graph
  • 0% sourcing coverage across sourced relationships
  • Tracked as established institution within the Healthcare & Life Sciences category

Executive Snapshot

Strategic Role
Established Institution
Sourcing Coverage
0%
View Methodology →

Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.

Ecosystem Influence
High
Strategic Momentum
Accelerating

Coverage

Mapped Relationships
2
Technology Domains
3

Strategic Implications

  • Central node connecting multiple strategic ecosystems
  • Directly influences technology and capital flows
  • Material relevance to downstream dependency mapping

Top Opportunities

Raised EBITA margin and free cash flow outlooks reflect continued execution on margin improvement initiatives alongside steady comparable sales growth.

Top Risks

Continues to compete against larger-scale rivals GE HealthCare and Siemens Healthineers in a capital-intensive medical imaging equipment market.

Critical Dependencies

Continue to Dependency Graph ↓

Dutch health technology company providing diagnostic imaging, image-guided therapy and patient monitoring systems; reported trailing 12-month revenue of $20.6 billion as of Q2 2026 with adjusted EPS of €0.49 (up 36.1% year-over-year), reiterated 2026 comparable sales growth outlook of 3-4.5%, and raised its adjusted EBITA margin outlook to 13.5-14%.

Additional Intelligence Signals

Patent citation lineage, earnings-call mentions, and federal contract disclosures — automatically collected, not yet visible anywhere else on the site.

Federal contract disclosures

Department of Health and Human Services — $68,167,100: THIS SYSTEM WOULD BE USED AND INTEGRATED WITHIN ROUTINE CARE FOR BURNS AND TRAUMATIC INJURIES, BUT WOULD ALSO HAVE THE POTENTIAL TO BE OF USE IN DETECTION VIRAL PNEUMONIA OF COVID 19 CASES.

USAspending.gov · May 8, 2020

Department of Defense — $14,851,290: RAPIDLY OPERATIONALIZE THE RAPID ANALYSIS OF THREAT EXPOSURE (RATE) ALGORITHM

USAspending.gov · Apr 9, 2020

Department of Defense — $9,171,468: 8511723402!PATIENT MONITORING SYS

USAspending.gov · Nov 5, 2025

Department of Veterans Affairs — $7,533,134: TELECC IDIQ TASK ORDER 41

USAspending.gov · Aug 30, 2026

Department of Veterans Affairs — $6,970,338: SERVICING PHILIPS EQUIPMENT

USAspending.gov · Nov 1, 2020

Sources

Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.

Evidence

1 source

  • PhilipsPhilips announces its 2026 Second-Quarter Resultscompany

Correlated Activity

Both Philips and GE HealthCare which it depends on — are showing accelerating Activity at the same time (1 recorded change for GE HealthCare in the last 90 days).

Timing correlation only — not evidence of a causal link

Both Philips and Siemens Healthineers which it depends on — are showing accelerating Activity at the same time (1 recorded change for Siemens Healthineers in the last 90 days).

Timing correlation only — not evidence of a causal link

Both Philips and ResMed which depends on it — are showing accelerating Activity at the same time (1 recorded change for ResMed in the last 90 days).

Timing correlation only — not evidence of a causal link

Acquisition & Investment Fit

AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.

Relationship Map

The relationships surrounding Philips — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.

Connection type

Sign in free to click a node and explore →

Click any node to make it the new center. Scroll to zoom, drag to pan.

The Story So Far (last 6 months)

Jul 2026: Q2 2026 adjusted EPS rises 36% to €0.49; raises margin outlookJul 2026: Philips announces its 2026 Second-Quarter Results

Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.

Philips's Timeline

A sourced, dated history of Philips's key moments — founding to present.

  1. Jul 2026 · Q2 2026 adjusted EPS rises 36% to €0.49; raises margin outlook

    Philips reported Q2 2026 adjusted earnings of €0.49 per share, up 36.1% from €0.36 a year earlier, and raised its 2026 adjusted EBITA margin outlook to 13.5-14% from 12.5-13%, while reiterating comparable sales growth guidance of 3-4.5% and increasing its free cash flow forecast to €1.5-1.7 billion.